Thermo Fisher Scientific Inc.
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific Adjusted ROIC — Trailing 5-Quarter Average by Quarter
Adjusted ROIC — Trailing 5-Quarter Average (%)
Thermo Fisher Scientific Adjusted ROIC — Trailing 5-Quarter Average: 11.0% in Q3 2026, down 0.3 pts from a year earlier.
Where the Q3 2026 figure comes from
“Adjusted ROIC (non-GAAP measure) 12.0 % 11.6 % 11.3 % 11.0 % 10.9 % 11.0 %”
Source: Q3 2026 Reconciliation of Financial Information ↗
Core M&A capital allocation efficiency metric for TMO: TTM Adjusted NOPAT divided by trailing 5-quarter average invested capital.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up adjusted ROIC — Trailing 5-Quarter Average
- TTM Adjusted NOPAT (12-Month)9,662 · Q3 2026
- Trailing 5-Quarter Average Invested Capital87,609 · Q3 2026
- Adjusted ROE18.3% · Q3 2026
- Trailing 5-Quarter Average Equity52,767 · Q3 2026
- Total Debt / TTM EBITDA3.60 · Q3 2026
- Total Debt / Adjusted TTM EBITDA3.40 · Q3 2026
- Net Debt / TTM EBITDA3.10 · Q3 2026
- Net Debt / Adjusted TTM EBITDA2.90 · Q3 2026
Cite this data
StockData. (2026). Thermo Fisher Scientific Adjusted ROIC — Trailing 5-Quarter Average (%), quarterly Q4 2021–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/adj-roic-pct
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.